血液透析患者的高血压药物控制
朱孔彩， 曹国颖， 胡欣 - 中国药学(英文版), 2012 - jcps.bjmu.edu.cn
… primarily through changes in left ventricular output rather than … patients with ESRD and
healthy population. In a study of antihypertensive treatment with amlodipine (CCB) and valsartan (…
healthy population. In a study of antihypertensive treatment with amlodipine (CCB) and valsartan (…
沙库巴曲缬沙坦对心肌梗死后心力衰竭患者的临床疗效
熊振宇， 满万荣， 李越洋， 郭文怡， 王海昌， 孙冬冬 - 心脏杂志, 2020 - heartj.cn
… effects of sacubitril/valsartan versus valsartan on cardiac functions … failure patients.
METHODS From … , the improvements of LVEF and ESV in sacubitril/valsartan group were also …
METHODS From … , the improvements of LVEF and ESV in sacubitril/valsartan group were also …
Songling Xuemaikang Capsule (松龄血脉康胶囊) for primary hypertension: a systematic review of randomized controlled trials
X Yang, X Xiong, G Yang, H Wang, J Wang - Chinese journal of integrative …, 2015 - Springer
… Four trials of SXC plus valsartan show no homogeneity in the … be considered before
accepting the findings of this paper. … combined with captopril on the quality of life of patients with …
accepting the findings of this paper. … combined with captopril on the quality of life of patients with …
[PDF][PDF] 急性心肌梗死患者应用沙库巴曲缬沙坦治疗研究进展
谭慧， 唐关敏 - 心电与循环 - xdyxh.com
… Changes in ventricular size and function in patients treated with valsartan,captopril,or both
… : considerations for the management of heart failure with sacubitril/valsartan[J]. Vasc Health …
… : considerations for the management of heart failure with sacubitril/valsartan[J]. Vasc Health …
糖尿病大鼠心肌缺血再灌注血管紧张素变化
刘文艳， 马越娇， 李屹， 刘晓舒， 杨鑫， 张建军， 车光昇… - 中国公共卫生, 2013 - zgggws.com
… Changes of angiotensin in diabetic rats with myocardial ischemic/reperfusion injury[J].
Chinese Journal of Public Health, 2013, 29(1): 64-65. doi: 10.11847/zgggws2013-29-01-20 …
Chinese Journal of Public Health, 2013, 29(1): 64-65. doi: 10.11847/zgggws2013-29-01-20 …
血管收縮素對心臟細胞的第二型血管收縮素轉化酶表現調節與第二型基質金屬蛋白酶表現之影響
關棠青， 林志生 - 2013 - ir.lib.nycu.edu.tw
… change, which heart structure change forms heart remodeling and leads to most heart diseases
such as cardiac hypertrophy, heart failure … All samples were presence of 1 μM captopril (…
such as cardiac hypertrophy, heart failure … All samples were presence of 1 μM captopril (…
血管收縮素II 與血管收縮素1-7 於人類心臟纖維母細胞中對心臟血管收縮素轉化酶II 的表現調節
溫証皓， 林志生 - 2008 - ir.lib.nycu.edu.tw
… ACE2 promoter activity could be abolished when the HCF cells pretreated with Valsartan. …
and interstitial changes and manifested clinically as changes in size, shape and function of the …
and interstitial changes and manifested clinically as changes in size, shape and function of the …
[PDF][PDF] 缺血性卒中或短暂性脑缺血发作患者的卒中预防指南
RL Sacco, R Adams, G Albers, MJ Alberts… - 中华脑血管病 …, 2006 - sasg.com.cn
… 在高 血压最佳治疗(Hypertension Optimal Treatment, HOT )研究和欧洲收缩期高血压( Systolic
Hypertension in Europe, Syst-Eur)试验中,未发现 CCB 与ACEI,BB 和利尿药联合应用与心血管…
Hypertension in Europe, Syst-Eur)试验中,未发现 CCB 与ACEI,BB 和利尿药联合应用与心血管…